Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Functional characterization of polymorphisms in the human TFPI gene.

Skretting G, Stavik B, Landvik NE, Myklebust CF, Iversen N, Zienolddiny S, Sandset PM.

Biochem Biophys Res Commun. 2010 Jun 18;397(1):106-11. doi: 10.1016/j.bbrc.2010.05.078. Epub 2010 May 16.

PMID:
20519147
2.

A new T-287C polymorphism in the 5' regulatory region of the tissue factor pathway inhibitor gene. Association study of the T-287C and C-399T polymorphisms with coronary artery disease and plasma TFPI levels.

Moatti D, Haidar B, Fumeron F, Gauci L, Boudvillain O, Seknadji P, Olliver V, Aumont MC, de Prost D.

Thromb Haemost. 2000 Aug;84(2):244-9.

PMID:
10959696
3.
4.

Tissue factor pathway inhibitor polymorphisms in women with and without a history of venous thrombosis and the effects of postmenopausal hormone therapy.

Opstad TB, Eilertsen AL, Høibraaten E, Skretting G, Sandset PM.

Blood Coagul Fibrinolysis. 2010 Sep;21(6):516-21. doi: 10.1097/MBC.0b013e32833a06cd.

PMID:
20453636
5.

Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V Leiden.

Lincz LF, Adams MJ, Scorgie FE, Thom J, Baker RI, Seldon M.

Blood Coagul Fibrinolysis. 2007 Sep;18(6):559-64.

PMID:
17762532
6.

Association analysis of tissue factor pathway inhibitor polymorphisms and haplotypes with osteonecrosis of the femoral head in the Korean population.

Dai XL, Hong JM, Oh B, Cho YS, Lee JY, Park EK, Kim CY, Kim SY, Kim TH.

Mol Cells. 2008 Nov 30;26(5):490-5.

7.

Polymorphisms in the tissue factor pathway inhibitor gene are not associated with ischaemic stroke.

Sayer MS, Cole VJ, Adams MJ, Baker RI, Staton JM.

Blood Coagul Fibrinolysis. 2007 Oct;18(7):703-8.

PMID:
17890962
8.

Polymorphisms in antithrombin and in tissue factor pathway inhibitor genes are associated with recurrent pregnancy loss.

Guerra-Shinohara EM, Bertinato JF, Tosin Bueno C, Cordeiro da Silva K, Burlacchini de Carvalho MH, Pulcineli Vieira Francisco R, Zugaib M, Cerda A, Morelli VM.

Thromb Haemost. 2012 Oct;108(4):693-700. Epub 2012 Aug 23.

PMID:
22918506
9.

Polymorphisms in the 5' regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: the ECTIM and PATHROS studies. Etude Cas-Témoins de l'Infarctus du Myocarde. Paris Thrombosis case-control Study.

Arnaud E, Barbalat V, Nicaud V, Cambien F, Evans A, Morrison C, Arveiler D, Luc G, Ruidavets JB, Emmerich J, Fiessinger JN, Aiach M.

Arterioscler Thromb Vasc Biol. 2000 Mar;20(3):892-8.

10.

Identification of a regulatory single nucleotide polymorphism in the adiponectin (APM1) gene associated with type 2 diabetes in Han nationality.

Yang M, Qiu CC, Chen W, Xu LL, Yu M, Xiang HD.

Biomed Environ Sci. 2008 Dec;21(6):454-9. doi: 10.1016/S0895-3988(09)60002-7.

PMID:
19263799
11.

Polymorphisms in the 5'-untranslated region of the human serotonin receptor 1B (HTR1B) gene affect gene expression.

Duan J, Sanders AR, Molen JE, Martinolich L, Mowry BJ, Levinson DF, Crowe RR, Silverman JM, Gejman PV.

Mol Psychiatry. 2003 Nov;8(11):901-10.

PMID:
14593427
12.

Allelic diversity in the TGFB1 regulatory region: characterization of novel functional single nucleotide polymorphisms.

Shah R, Rahaman B, Hurley CK, Posch PE.

Hum Genet. 2006 Mar;119(1-2):61-74. Epub 2005 Dec 14.

PMID:
16369764
13.

Regulatory region variability in the human presenilin-2 (PSEN2) gene: potential contribution to the gene activity and risk for AD.

Riazanskaia N, Lukiw WJ, Grigorenko A, Korovaitseva G, Dvoryanchikov G, Moliaka Y, Nicolaou M, Farrer L, Bazan NG, Rogaev E.

Mol Psychiatry. 2002;7(8):891-8.

14.

Analysis of the tissue factor pathway inhibitor gene and antigen levels in relation to venous thrombosis.

Amini-Nekoo A, Futers TS, Moia M, Mannucci PM, Grant PJ, Ariëns RA.

Br J Haematol. 2001 May;113(2):537-43.

PMID:
11380428
15.

A locus on chromosome 2 influences levels of tissue factor pathway inhibitor: results from the GAIT study.

Almasy L, Soria JM, Souto JC, Warren DM, Buil A, Borrell M, Muñoz X, Sala N, Lathrop M, Fontcuberta J, Blangero J.

Arterioscler Thromb Vasc Biol. 2005 Jul;25(7):1489-92. Epub 2005 Apr 21.

16.

C-399T polymorphism in the promoter region of human tissue factor pathway inhibitor (TFPI) gene does not change the plasma TFPI antigen level and does not cause venous thrombosis.

Miyata T, Sakata T, Kumeda K, Uchida K, Tsushima M, Fujimura H, Kawasaki T, Kato H.

Thromb Haemost. 1998 Aug;80(2):345-6. No abstract available.

PMID:
9716167
17.

Polymorphisms of the tissue factor pathway inhibitor (TFPI) gene in patients with acute coronary syndromes and in healthy subjects : impact of the V264M substitution on plasma levels of TFPI.

Moatti D, Seknadji P, Galand C, Poirier O, Fumeron F, Desprez S, Garbarz M, Dhermy D, Arveiler D, Evans A, Luc G, Ruidavets JB, Ollivier V, Hakim J, Aumont MC, de Prost D.

Arterioscler Thromb Vasc Biol. 1999 Apr;19(4):862-9.

18.

The -33T-->C polymorphism in intron 7 of the TFPI gene influences the risk of venous thromboembolism, independently of the factor V Leiden and prothrombin mutations.

Ameziane N, Seguin C, Borgel D, Fumeron F, Moatti D, Alhenc-Gelas M, Grandchamp B, Aiach M, Emmerich J, de Prost D.

Thromb Haemost. 2002 Aug;88(2):195-9.

PMID:
12195688
20.

Association of Asn221Ser mutation in tissue factor pathway inhibitor-beta with plasma total tissue factor pathway inhibitor level.

Ishikawa J, Okada H, Kato H, Takeshita S, Honda S, Kawasaki T, Suehisa E, Tsuji H, Madoiwa S, Sakata Y, Kojima T, Murata M, Ikeda Y, Kokubo Y, Okamura T, Tomoike H, Miyata T.

Blood Coagul Fibrinolysis. 2009 Jan;20(1):22-6. doi: 10.1097/MBC.0b013e328304e0b9.

PMID:
20523161

Supplemental Content

Support Center